QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.10 (-0.86%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.10 (-0.86%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.10 (-0.86%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.10 (-0.86%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

LianBio (LIAN) SEC Filings & 10K Form

$0.30
+0.01 (+3.45%)
(As of 04/15/2024 ET)

Recent LianBio SEC Filings

DateFilerForm TypeView
04/11/2024
3:10 PM
Gu Ehong (Reporting)
LianBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
7:00 AM
LianBio (Filer)
Form 15-12G
03/12/2024
11:15 PM
LianBio (Filer)
Form EFFECT
03/12/2024
7:30 AM
Citibank,N.A./ADR (Filed by)
LianBio (Subject)
Form F-6 POS
03/12/2024
6:56 AM
LianBio (Filer)
Form POS AM
03/12/2024
7:00 AM
LianBio (Filer)
Form S-8 POS
03/12/2024
7:01 AM
LianBio (Filer)
Form S-8 POS
03/12/2024
7:02 AM
LianBio (Filer)
Form S-8 POS
03/11/2024
6:51 AM
LianBio (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
02/29/2024
6:45 PM
LianBio (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13D/A
02/20/2024
4:23 PM
LianBio (Issuer)
Stone Adam Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:25 PM
EDELMAN JOSEPH (Reporting)
LianBio (Issuer)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:27 PM
LianBio (Issuer)
Poukalov Konstantin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
6:04 AM
LianBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
5:13 AM
LianBio (Subject)
Wang Yizhe (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2023
6:56 AM
LianBio (Subject)
Wang Yizhe (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
3:10 PM
Gu Ehong (Reporting)
LianBio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2023
7:05 AM
LianBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
3:23 PM
LianBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2023
4:08 PM
LianBio (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13D
10/30/2023
3:16 PM
LianBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
3:21 PM
LianBio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/23/2023
3:17 PM
LianBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
3:20 PM
LianBio (Issuer)
Silbermann Susan Michele (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:22 PM
GIANAKAKOS ANASTASIOS (Reporting)
LianBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:23 PM
Chen Wei Wei (Reporting)
LianBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:09 PM
EDELMAN JOSEPH (Reporting)
LianBio (Issuer)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:10 PM
LianBio (Issuer)
Poukalov Konstantin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:11 PM
LianBio (Issuer)
Stone Adam Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2023
3:33 PM
LianBio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2023
6:28 AM
LianBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2023
11:15 PM
LianBio (Filer)
Form EFFECT
04/26/2023
7:07 AM
LianBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2023
7:23 AM
LianBio (Filer)
Form S-3/A
04/19/2023
3:17 PM
LianBio (Filer)
Form DEF 14A
04/19/2023
3:21 PM
LianBio (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:LIAN) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners